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Background: Bovine tuberculosis (bTB; Mycobacterium bovis) remains a significant
problem in a number of countries, and is often found where M. avium subsp.
paratuberculosis (MAP) is also present. In the United Kingdom, bTB has been difficult
to eradicate despite long-term efforts. Co-infection has been proposed as one partial
mechanism thwarting eradication.
Methods: A retrospective case-control study of 4,500 cattle herds in Northern Ireland,
where serological testing of cattle for MAP, was undertaken (2004–2015). Blood samples
were ELISA tested for MAP; infection of M. bovis was identified in herds by the
comparative tuberculin test (CTT) and through post-mortem evidence of infection.
Case-herds were those experiencing a confirmed bTB breakdown; control-herds were
not experiencing a breakdown episode at the time of MAP testing. A second model
included additional testing data of feces samples (culture and PCR results) to better
inform herd MAP status. Multi-level hierarchical models were developed, controlling for
selected confounders. A sensitivity analysis of the effect of MAP sample numbers per
event and the prior timing of tuberculin-testing was undertaken.
Results: 45.2% (n = 250) of case observations and 36.0% (3,480) of control
observations were positive to MAP by ELISA (45.8% and 36.4% when including ancillary
fecal testing, respectively). Controlling for known confounders, the adjusted odds ratio
(aOR) for this association was 1.339 (95%CI:1.085–1.652; including ancillary data
aOR:1.356;95%CI:1.099–1.673). The size-effect of the association increased with the
increasing number of samples per event used to assign herd MAP status (aOR:1.883 at
>2 samples, to aOR:3.863 at >10 samples), however the estimated CI increased as N
decreased. 41.7% of observations from chronic herds were MAP serology-positive and
32.2% from bTB free herds were MAP positive (aOR: 1.170; 95%ci: 0.481–2.849).
Byrne et al. MAP Co-infection Impacts bTB Risk
Discussion: Cattle herds experiencing a bTB breakdown were associated with
increased risk of having a positive MAP status. Chronic herds tended to exhibit higher
risk of a positive MAP status than bTB free herds, however there was less support for this
association when controlling for repeated measures and confounding. MAP co-infection
may be playing a role in the success of bTB eradiation schemes, however further studies
are required to understand the mechanisms and to definitively establish causation.
Keywords: bovine TB, Johne’s disease, veterinary epidemiology, co-infection, infectious disease control,
mycobacteria
INTRODUCTION
Chronic mycobacterial infections are some of the most
challenging pathogens to eradicate at national and international
scales, requiring large-scale long-term coordinated eradication
efforts (1–3). For the United Kingdom, bovine tuberculosis
(caused by infection with the pathogen Mycobacterium bovis)
remains one of the highest priority pathogens affecting cattle
farming industries, and one of the most costly pathogens to
control to the state (4, 5). Indeed, in Northern Ireland alone,
the annual cost of the eradication program in recent years
has exceeded £30 million (http://www.tbhub.co.uk/tb-policy/
northern-ireland/). Eradication in the UK is primarily predicated
on the accurate identification of the pathogen within herds
using a screening comparative tuberculin test (using bovine
and avian tuberculins) to allow the slaughter of test positive
animals. Subsequent repeated tuberculin testing is undertaken,
and where there is evidence of within herd transmission,
ancillary testing using the more sensitive interferon gamma
test, and removal of additional test positive animals may be
undertaken (6). The sensitivity of the screening test (single
intradermal cervical comparative tuberculin (SICCT) test) is
known to be moderate and can be variable in performance (7–
10). A further complication is the presence of a known wildlife
reservoir species that can harbor widespread and high levels of
infection (11, 12), and which cull trials have provided evidence
to suggest are involved in the risk of infection within cattle
herds (13, 14). Despite these issues, modeling studies suggest
that the mean reproductive number of the system (R0), which
determines whether infection will be maintained in populations
in perpetuity, is only slightly above 1 (15–17). Therefore, only
small positive changes to the eradication program could bring
the trajectory below 1, which would in the long-term lead to
eradication (5).
M. avium subsp. paratuberculosis (MAP) is the causative agent
of Johne’s disease, another significant mycobacterial pathogen of
cattle, which can impact production and thus lead to economic
loses to farmers (18). Unlike bTB, Johne’s disease is not a statutory
pathogen in Britain and Ireland, however, it is considered a
priority non-regulatory pathogen of concern to farmers (19).
There is evidence that co-infection of MAP can impact on the
immunological response to tuberculins during statutory bTB skin
testing and interferon gamma tests (20–24). This is due to cross-
reactivity, primarily on the avian tuberculin (which is derived
fromM. avium), but also impacts the reaction size on the bovine
injection site (21, 25). Such cross-reactivity effects can lead to
misdiagnosis (7, 26), allowing for TB positive animals to be
mistakenly retained within herds. One could hypothesize that
these processes may have impacts on the ability to clear infection
once detected within herds (21), and subsequently impacts the
duration of breakdown episodes. Unsurprisingly, the exposure
to M. bovis can also have an impact on the performance of
diagnostics for MAP (27). Therefore, it can be challenging to
assign mechanistic inference, as the timing of infections and the
testing regimes will have an impact on patterns that emerge from
co-infected herds. For example, evidence suggests that tuberculin
testing may impact on serum and milk ELISA testing for MAP,
causing an increased risk of false positive disclosure (25, 28).
Despite this, there is some epidemiological evidence that co-
infection can hamper the ability to accurately identify infected
animals and to clear infection from herds when the primary aim
is either to eradicate bTB [e.g., (23)] or MAP [e.g., (27)].
In this study, we undertook a retrospective case-control
study to investigate the hypothesis that there was an association
between MAP herd status and the probability of a herd
experiencing a confirmed bTB breakdown episode. We also
wanted to investigate whether there were any patterns of
co-infection and the longer-term bTB status of herds. We
hypothesized that herds with “chronic” (i.e., long-term and
recurrent problem herds) TB infection may be more likely to
have evidence of co-infection than herds that did not experience
chronic infections.
METHODS
A retrospective, case-control study of cattle herds in
Northern Ireland (United Kingdom) was undertaken (2004–
2015). The primary dataset utilized during the study included
serological testing data generated from surveillance activities, but
primarily from part of a cattle health scheme in Northern Ireland
undertaken by the Agri-food and Biosciences Institute (AFBI;
www.afbi.gov.uk). These data included all blood (serological)
tests undertaken during voluntary submissions, as well as
those made by members of AFBI Cattle Health Scheme (CHS).
Therefore, inclusion criteria restricted herds to those sampled
and which voluntarily participated in MAP control schemes
in Northern Ireland. It should be noted that all samples were
handled and tested in the same way within AFBI irrespective of
the scheme from which samples were received.
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The AFBI CHS is a voluntary scheme which provides a
structured approach to the control of five endemic diseases of
cattle including Johne’s disease. The scheme is licensed by Cattle
Health Certification Standards (CHeCS) which provides the
standards for licensed health schemes within the UK and Ireland.
Herds enrolled in the Johne’s programme have to carry out an
annual herd screen consisting on blood testing all animals 2 years
of age or older within the herd. In low seroprevalence herds,
seropositive animals could be re-tested by fecal culture or PCR to
determine the status (below for more). Introduced animals had
to be blood/fecal sampled in isolation prior to joining the herd
independently of the age.
Bloods were primarily sampled during concurrent statutory
test sampling [i.e., TB testing or brucellosis monitoring; (29)]. All
veterinarians and herd owners involved in CHS and other
voluntary MAP testing with AFBI were given advice to avoid
cross-reactions following intradermal tuberculin testing by either
blood sampling on the first day of the test or waiting 3
months. These samples were date stamped within the dataset
with the submission to the laboratory, with the statutory
key performance indicator (KPI) ensuring that samples were
processed within a week or less (S. Verner, pers. comm.).
It should be noted that not all samples were taken at the
same time as those for ancillary tests, with a risk that the
time between sampling and sample submission within the
field may have varied (e.g., the fecal samples, see below).
However, we have no evidence to support the hypothesis that
there would be any systematic bias in submission times. We
assumed this random error contributed to the uncertainty in the
error in our models, but potentially erring the models toward
the null.
The testing was undertaken in the Diagnostic Surveillance
and Investigation Branch (DSIB) at AFBI, Stormont. Blood
samples were tested using the IDEXX Paratuberculosis Screening
AB ELISA Test (formerly Pourquier) as per the manufacturer’s
recommendations. This test was accredited to ISO17025
standard. Additional information on kits used and laboratory
procedures are presented in the Supplementary Material. There
were also a small number of feces samples taken from animals
within herds where MAP was suspected (after a positive ELISA
result or clinical suspicion) or from animals added to AFBI CHS
herds in the Johne’s programme. These samples were tested for
MAP via culturing of the pathogen in the laboratory (30), or
using PCR methodologies (see Supplementary Material). These
ancillary data were added to the serological dataset to improve
the ability to designate a MAP herd status.
For the purposes of the present study, for each herd, a MAP
status was attributed to the herd at the date of MAP testing. If any
positive result for MAP was disclosed from the dataset, then the
herd was attributed a “positive status” for that test event (note,
this is not necessarily the case for the program, where a herd
is not considered positive with a single seropositive result due
to imperfect test specificity). Herds could be represented in the
dataset on multiple occasions as repeated MAP tests occurred
over the time series.
The Animal and Public Health and Information System
(APHIS) maintained by the Department of Agriculture,
Environment and Rural Affairs (DAERA, Northern Ireland) was
used to gain information on herd bovine tuberculosis status,
as well as deriving data on herd type, whether the herd held a
milk license, which DVO the herd was assigned to, the number
of animals moving into a herd per annum (buying in), and for
estimating herd size.
STUDY DESIGN AND MODELING
The outcome variable of interest was the binary bTB status
of herds at the time of the MAP testing event. The bTB
status of the herd was based on breakdown episodes (31, 32).
An episode was a period of time a herd was undergoing
a breakdown, and was defined as the period from the first
disclosing test to the last test at which the herd was released from
restriction [for more on this classification see (31, 32)]. Only
episodes whereby TB was post-mortem laboratory confirmed
during an episode were included in this episode file (these are
either multiple reactor breakdowns and/or breakdowns triggered
by the presence of a TB lesion). Laboratory confirmation
in Northern Ireland includes histopathology, culture, and/or
strain/genotyping [spoligotyping and Variable Number Tandem
Repeat genotyping; (33)]. This episode file then allowed for
each herd to be classified as either “within episode,” which
was our cases, and “not experiencing a breakdown” which
was our control observations at the time of the MAP
test event.
The primary explanatory variable was herd MAP status at the
test event level based on the serological ELISA test classification.
A secondary model also included ancillary data (feces) to classify
herds with regards MAP. It is important to note that MAP and
bTB are currently not co-managed in Northern Ireland as part of
the bTB eradication scheme.
Bovine TB has a complex epidemiology, and we wanted to
control for the most significant confounders of bTB risk in
Northern Ireland but limiting the number of parameters in
our model to ensure the model was reasonably parsimonious.
Given previous experience in Northern Ireland [e.g., (6)] and
published reviews of the literature [e.g., (34)], we made the
a-priori decision to control for herd type [measured in two
ways (Table 1)], herd size, number of animals bought in to the
herd during the test year, and region (based on 10 District
Veterinary Office administrative areas), while controlling for
the non-independence of repeated observations within the same
herd as a baseline model. We also tested whether there was any
evidence of significant 2-way interactions between MAP status
and (i) herd type (ii) herd size (iii) buying in, and also whether
there was an interaction between herd type and (i) herd size
(ii) buying in. Year was additionally tested for inclusion as a
linear predictor, as a quadratic function (year2), as the natural log
[log(year)], and a triennial categorical variable (dummy variable
with four categories). Details of the variable are presented in
Table 1. It should be noted that two herd-type variables were
considered, HERD_TYPE and MILK_LICENSE. HERD_TYPE
contained information about the enterprise type classification
used in APHIS but also had somemissing classifications, whereas
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TABLE 1 | Cross-tabulations and univariable analysis of the relationship between explanatory variables and bovine TB episode cases (positive) and controls (negative) in
cattle herds in Northern Ireland.
TB negative TB positive Total OR Lower 95%CI Upper 95%CI
MAP SERUM ELISA
Negative 6,186 303 6,489 ref.
% 95.33 4.67 100
Positive 3,480 250 3,730 1.467 1.234 1.743
% 93.3 6.70 100
MAP STATUS (SERUM+FECES)
Negative 6,152 300 6,452 ref.
% 95.35 4.65 100
Positive 3,514 253 3,767 1.476 1.243 1.754
% 93.28 6.72 100
YEAR
2004–2006 515 31 546 ref.
% 94.32 5.68 100
2007–2009 749 46 795 1.020 0.618 1.683
% 94.21 5.79 100
2010–2012 3,716 225 3,941 1.006 0.664 1.523
% 94.29 5.71 100
2013–2015 4,686 251 4,937 0.890 0.589 1.344
% 94.92 5.08 100
HERD_TYPE
Beef 4,363 188 4,551 ref.
% 95.87 4.13 100
Dairy 3,557 300 3,857 1.957 1.623 2.361
% 92.22 7.78 100
Other/missing 1,746 65 1,811 0.864 0.648 1.152
% 96.41 3.59 100
MILK LICENSE
Yes 6,446 280 6,726 1.952 1.643 2.318
% 95.84 4.16 100
No 3,220 273 3,493 ref.
% 92.18 7.82 100
dvo_code
1 762 47 809 ref.
Armagh 94.19 5.81 100
2 360 11 371 0.495 0.254 0.966
Ballymena 97.04 2.96 100
3 1,049 58 1,107 0.896 0.603 1.332
Coleraine 94.76 5.24 100
4 1,355 61 1,416 0.730 0.494 1.079
Dungannon 95.69 4.31 100
5 1,257 64 1,321 0.825 0.561 1.216
Enniskillen 95.16 4.84 100
6 264 9 273 0.553 0.267 1.143
Larne 96.7 3.3 100
7 366 21 387 0.930 0.548 1.579
Derry/Londonderry 94.57 5.43 100
8 1,293 89 1,382 1.116 0.775 1.607
Newry 93.56 6.44 100
9 1,076 90 1,166 1.356 0.942 1.953
Newtownards 92.28 7.72 100
10 1,884 103 1,987 0.886 0.621 1.264
(Continued)
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TABLE 1 | Continued
TB negative TB positive Total OR Lower 95%CI Upper 95%CI
Omagh 94.82 5.18 100
BUYING IN (MEAN; RANGE)
Q1 (0.389; <2) 2,711 152 2,863 ref.
% 94.69 5.31 100
Q2 (3.205; 2–5) 2,162 96 2,258 0.792 0.610 1.029
% 95.75 4.25 100
Q3 (10.416; 6–17) 2,481 110 2,591 0.791 0.615 1.017
% 95.75 4.25 100
Q1 (75.280; >17) 2,312 195 2,507 1.504 1.208 1.873
% 92.22 7.78 100
HERD SIZE (MEAN; RANGE)
Q1 (23.451; <42) 2,570 36 2,606 ref.
% 98.62 1.38 100
Q2 (63.924; 42–90) 2,435 85 2,520 2.492 1.681 3.694
% 96.63 3.37 100
Q2 (133.823; 91–194) 2,386 161 2,547 4.817 3.342 6.943
% 93.68 6.32 100
Q1 (370.628; >195) 2,275 271 2,546 8.504 5.979 12.095
% 89.36 10.64 100
MILK_LICENSE only allowed for binary classification of herds to
those with/without a milk license irrespective of main enterprise
type recorded within the APHIS dataset.
Simple unadjusted associations between variables was assessed
using logistic regression. For the multivariable models, the data
were fitted to a binary logit random effect regression model
(random effect = herd_id). All independent variables were
included in all models, with the exception of HERD_TYPE and
MILK_LICENSE, which were entered into competing models
and the model with the lowest Akaike’s Information Criteria
(AIC) value was considered the better fitting model. Where the
difference in AIC was <2, models were considered equivalent
(35). The random effect model was compared with a logistic
regression to assess if there was significant clustering within the
dataset, with a likelihood-ratio test of the intraclass correlation
(ICC; ρ) being statistically different from zero. The classification
ability of the model was assessed by calculating the Area under
the ROC (AUC), with a model with >0.7 considered exhibiting
reasonable performance.
SENSITIVITY ANALYSIS
The mean number of animals sampled for Johne’s Disease per
herd per event was 10.02 (SD: 34.091), however there was a
large variance in the distribution with the median sample of 1.
The sensitivity of ELISA tests for MAP can be low [e.g., 26%;
(36)], and can depend on the infectious stage of the host (37),
and thus can also be highly variable in terms of performance.
Recent work from the UK has suggested that moving toward
a more probabilistic interpretation of MAP ELISA tests based
on multiple (repeat) samples could improve the ability to assign
infection status (38). Therefore, we undertook a sensitivity
analysis, where separate models were fitted with the minimum
number of samples per herd per event varying from ≥2 to
≥10. In each model, covariates were included [herd-type, herd-
size, numbers of animals bought into the herd during the year
of testing, region (DVO)], and a herd-level random effect was
included to control for repeated measures within herds. The
adjusted odds ratio (aOR; 95%ci), the number of observations,
and the number of herds represented in the dataset for each
model was reported. We also assessed models in terms of
discrimination via the AUC and calibration via the Hosmer-
Lemeshow test (for fixed effects only).
Despite guidelines that recommend that MAP ELISA testing
should occur at least 3 months following an animal’s last TB
skin test (AHWNI 2018), there was a potential for some samples
to have been taken within this “risk window”. To investigate
this potential effect at the herd event-level, we used available
animal-level data on the timing of animal’s last bTB test prior to
the current sampling period (the week of the MAP/bTB test, as
generally MAP samples were taken on the first day of a SCITT
test). In total, there were approximately 54,000 animals and
85,000 MAP tests that we could associate with a bTB skin test
prior to the current skin test/MAP event. Recent research from
Ireland and the UK, suggests this risk window may be <71 days
(28, 39). Any MAP test events where one or more animals had a
tuberculin test within a 71 day risk window were then excluded,
and the final multivariable random effect model was refit and
parameter estimates compared as part of the sensitivity analysis.
CHRONIC STATUS
Milne et al. (31) and Milne et al. (32) used the episode file for
bTB breakdowns to assign a status to herds based on herds
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experiencing problematic prolonged or recurrent breakdowns.
Chronic cases were herds which experienced a prolonged (>365
days) or recurrent (1 breakdown of duration <1year, followed
by two or more bTB breakdowns within 2 years) over a time-
series 2004–2015 (32). We used this classification to stratify herds
recruited to the present study. We also included a classification
“Non-chronic episodic herd” for herds that experienced at least
one episode during the time series that were non-chronic in
nature. We investigated whether there was any relationship
between MAP risk and chronic herd status.
RESULTS
Summary Statistics
There were 10,219 observations (events) where one or more
MAP tests occurred constituting 553 (5.4%) TB cases and
9,666 (94.6%) controls. MAP positive results were disclosed at
3,730/10,219 (36.5%) events. Cross-tabulations at the event level
between TB cases/controls and predictor variables are presented
in Table 1.
Overall, 43.0% of herds (1,933/4,500) exhibited at least 1
MAP serum positive sample over the study period. 9.2% of
herds (414/4,500) experienced a bTB breakdown episode during
a MAP testing event. Aggregating across the whole period of
the study, 138 (3.1%) herds were deemed ‘chronic’ breakdown
herds (i.e., experienced at least one chronic breakdown over the
period), 2,237 (49.7%) were non-chronic breakdown herds (i.e.,
experienced at least one breakdown over the period, but this
breakdown did not constitute a chronic breakdown), and 2,125
(47.2%) did not experience an episode over the period of the
study (i.e., clear of infection over the whole study period).
Univariable Modeling
The unadjusted univariable associations between explanatory
variables and the outcome is presented in Table 1. There was
evidence of increased risk of a herd experiencing a bTB episode
when disclosing with a MAP serum ELISA positive result (OR:
1.467 95%ci: 1.234–1.743), having an overall positive MAP status
(serum plus additional feces data; OR: 1.476 95%ci: 1.243–1.754),
being a dairy herd relative to a beef herd (OR: 1.957; 95%ci:
1.623–2.361), being in ArmaghDVO relative tomost other DVOs
(referent in Table 1) with the exception of Newry (OR:1.116;
95%ci: 0.775–1.607) or Newtownards (OR: 1.356; 95%ci: 0.942–
1.953). Increasing herd size was a risk factor (modeled as a
linear predictor scaled to per 100 animals: OR: 1.308; 95%ci:
1.263–1.354), as was buying-in of cattle during the test year
(linear predictor per 100 animals entering the farm: OR: 1.145;
95%ci: 1.087–1.207). There was little evidence of inter-annual
variation in risk (overall categorical: p = 0.651), nor trends
across years (modeled as linear: OR: 0.974; 95%ci: 0.940–1.009;
quadratic: OR 0.998; 95%ci: 0.996–1.000; log(year): OR 0.891;
95%ci: 0.732–1.083).
Multivariable Model
The final multivariable model (Table 2) did not include any
interaction terms as there was no evidence that these terms
improved the fit of the model (i.e., aORs straddled 0, AIC
increased with term addition). The model exhibited an adequate
discriminatory ability with an estimated AUC of 70.29 (95%ci:
68.10–72.47). Controlling for confounders, there remained
evidence that the MAP status of a herd as assessed using
serological testing was positively associated with bTB episode
risk at the time of testing (aOR: 1.339; 95%CI:1.085–1.652;
Table 2; including ancillary feces sample data: aOR: 1.356;
95%CI:1.099–1.673).
Sensitivity Analysis
The sensitivity analysis (Table 3; Figure 1) suggested that the
effect size of this association increased as the number of samples
used to inform the MAP status of herds increased. For example,
a model fitted where a minimum of 2 samples was used to
inform MAP herd status, suggested that bTB-MAP association
had an aOR of 1.883. Increasing the minimum sample to 5
resulted in an aOR of 2.500, at ≥10 samples the aOR was 3.863.
However, the overall sample (data set) size decreased with the
increasing minimum number of samples required to assign a
MAP status, and also the uncertainty in the parameter estimates
increased (Figure 1). Despite this, the model’s discriminatory
ability generally improved with increasing minimum number
of samples (minimum 1 sample AUC: 70.29; minimum of 10
samples AUC 75.80; Table 3), and calibration appeared not to
be a large problem (based on HL on fixed effects; Hosmer-
Lemeshow test: p > 0.2). It should be noted, that across
all 10 models where minimum sample number was varied,
the lower 95%CI aOR was always above 0, suggesting that
TABLE 2 | Multivariable random effect binary logit model of the association
between bovine TB (bTB) breakdown episode risk (outcome) and the M. avium
paratuberculosis status assessed using ELISA serum testing (primary explanatory
variable), while controlling for known bTB risk factors.
Explanatory variable aOR SE Lower 95%CI Upper95%CI
Serum neg. ref.
Serum pos. 1.339 0.144 1.085 1.652
Beef ref.
Dairy 1.141 0.183 0.834 1.562
Other/missing 0.877 0.202 0.558 1.377
Herd size (per 100 animals) 1.434 0.058 1.325 1.553
Buy in (per 100 animals) 1.203 0.052 1.105 1.309
Armagh ref.
Ballymena 0.692 0.315 0.284 1.687
Coleraine 1.162 0.353 0.640 2.109
Dungannon 0.970 0.287 0.544 1.731
Enniskillen 1.143 0.341 0.636 2.052
Larne 0.664 0.346 0.239 1.841
Derry/Londonderry 0.856 0.352 0.383 1.914
Newry 1.422 0.410 0.808 2.503
Newtownards 1.620 0.469 0.918 2.858
Omagh 1.211 0.333 0.707 2.075
Constant 0.008 0.002 0.005 0.015
ICC (ρ)* 0.426 0.040 0.351 0.505
*LR test of ρ = 0: χ2 (df: 1) = 143.05; Prob >= χ2 < 0.001.
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FIGURE 1 | The relationship between the number of serum samples used (2+
to 10+ per sampling event) to assign a herd-level status for Mycobacterium
avium paratuberculosis (MAP) and the estimated adjusted odds ratio (aOR) for
increasing bovine TB risk (left hand y-axis). The corresponding number of
observations and herds included in each model declined with increasing
minimum samples taken (right hand y-axis).
the association was robust across the different subsamples of
the population.
92.7% of MAP test events (9,477/10,219) were undertaken
outside of the risk window (i.e., not <71 days prior to
samples tested). The sensitivity analysis (Table 3) suggested
that excluding observations during the risk period increased
the uncertainty in the parameter estimates (e.g., 2+ samples,
excluding risk window obs: aOR: 1.597; 95%ci: 0.995–2.561). The
magnitude of point estimate for association between MAP and
bTB episode risk increased with increasing MAP samples used to
assign herd MAP-status. However, this too resulted in an overall
reduction in sample size. The highest AUC for any of the models
during the sensitivity analysis was 78.83 for a dataset excluding
observations within the risk window and having a minimum of
7 samples to inform the herd MAP status (aOR: 4.036; 95%ci:
1.451–11.226; n= 1160).
Chronic TB Herd—MAP Associations
Table 4 presents data on the cross-tabulation of the herd’s bTB
classification (31, 32) and their MAP status based on serology
ELISA testing. There was a marginally higher proportion of
serum positive MAP observations for chronic herds (41.67%),
than non-chronic episodic herds (39.85%), or bTB free herds
(32.22%). The association at the univariable level was moderate
and above 1 for the 95%ci (OR: 1.502; 95%ci: 1.185–1.906),
however the evidence in support of this association was found to
be weak when controlling for repeated measures (herd random
effect; OR: 1.403; 95%ci: 0.717–2.747) and when controlling for
confounders (RE plus confounders: aOR 1.170; 95%ci: 0.481–
2.849). There were 34 herds which had MAP tests undertaken
during chronic episodes. Removing these herds diminished the
difference between the proportion MAP positive from chronic
herds from 41.7% to 36.2%.
DISCUSSION
This study identified a robust association between confirmed
bovine TB breakdown episodic risk and herd MAP status,
based primarily on MAP serum ELISA testing with some
supplementary fecal testing. We found weaker evidence that
there was an association between the long-term categorization of
herds in terms of bTB risk (so called “chronic herds”). These data
form part of an emerging evidence base to suggest that Johne’s
disease, caused by MAP infection, could be impacting on the
dynamics of bTB in cattle herds, and consequently has a negative
impact on bTB disease eradication (20–24).
Previous research from Spain has suggested that co-infection
of MAP and bTB can lead to problems in clearing infection
(23). In a bullfighting herd where there was a mixed infection,
Alvarez et al. (23) showed that co-infection affected the sensitivity
of the skin test. Indeed, other researchers have found during
experimental co-infections that the performance of both the
skin test (based on Purified Protein Derivative (PPD) tuberculin
injection) and the interferon gamma test [e.g., (20, 30)] can
be affected. However, the direction of effects are not always
consistent across reported studies [e.g., (27, 40, 41)], but it
appears that overall the current consensus is that co-infection
reduces the sensitivity of tests for bTB (21), but may also
negatively impact on the specificity (indeed, there is still some
debate as to the dominant effect). Decreasing sensitivity of the
CTT could result in more bTB false-negative animals disclosed
in exposed herds, lowering the probability of truly infected herds
being disclosed. Also for herds that do breakdown, a lowering
of sensitivity increases the likelihood of infected animals being
missed during whole herd tests, resulting in either lengthening
of breakdowns or increasing the probability of recrudescence
(31). If MAP decreases the specificity of the CTT, then more
false positives would be disclosed. This could increase bTB
disclosure rates (i.e., could result in uninfected herds being
classed as experiencing a breakdown), however it should not
be a major factor when post-mortem/laboratory confirmation
of M. bovis infection is used to assign herd breakdown status
(as in the case during the present study). Specificity interference
could also affect the duration of breakdowns, as herds in the
UK only get released from bTB breakdowns when the herd
achieves clear CTT tests. In terms of epidemiological impact,
specificity interactions have financial and resource attribution
costs for control programs (i.e., the cost of culling uninfected
herds, and keeping trading restrictions in truly uninfected herds),
while sensitivity interactions have more direct consequences for
disease eradication programs as truly infected animals may not
be disclosed. It should be noted though, for bTB, multiple studies
have demonstrated that the CTT achieves very high specificity
[e.g., 100% (95% Bayes’CrI 99%, 100%) (9)], but moderate and
variable sensitivity performance [e.g., 50% (95% Bayes’ CrI:
26%, 78%; (9)].
TB in a herd can also affect the performance of the MAP
ELISA serum tests [e.g., (27)], potentially increasing the number
of false positives. Therefore, in our study, there was the risk that
herd’s MAP status could be affected by bTB presence. At the
animal level, leaving a minimum period between skin testing
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TABLE 3 | Adjusted odds ratio (aOR) for a MAP positive herd experiencing a bTB herd breakdown episode, depending on the number of samples used per herd per
event to categorize the herd’s MAP status.
Samples Including risk window Expl. Var. aOR SE Lower 95% Upper 95% N Herds AUC HL-test*
≥2 Yes MAP Serology 1.883 0.404 1.236 2.868 3,596 1490 73.31 0.267
≥2 No MAP Serology 1.597 0.385 0.995 2.561 2,908 1373 73.91 0.447
≥3 Yes MAP Serology 2.359 0.593 1.442 3.860 2,683 1093 73.61 0.500
≥3 No MAP Serology 2.148 0.647 1.190 3.877 1,896 899 74.45 0.265
≥4 Yes MAP Serology 2.351 0.657 1.359 4.066 2,340 963 74.12 0.301
≥4 No MAP Serology 2.170 0.769 1.083 4.347 1,586 771 74.55 0.841
≥5 Yes MAP Serology 2.500 0.753 1.386 4.511 2,124 892 74.82 0.570
≥5 No MAP Serology 2.493 1.006 1.130 5.499 1,391 693 76.76 0.758
≥6 Yes MAP Serology 2.571 0.818 1.379 4.796 1,968 828 74.82 0.106
≥6 No MAP Serology 2.804 1.244 1.175 6.689 1,259 640 77.68 0.762
≥7 Yes MAP Serology 3.038 1.084 1.509 6.114 1,857 782 75.80 0.367
≥7 No MAP Serology 4.036 2.107 1.451 11.226 1,160 591 78.83 0.881
≥8 Yes MAP Serology 2.827 1.015 1.399 5.713 1,769 751 74.82 0.350
≥8 No MAP Serology 3.549 1.869 1.264 9.964 1,084 560 77.88 0.942
≥9 Yes MAP Serology 3.648 1.445 1.679 7.929 1,692 719 75.49 0.512
≥9 No MAP Serology 4.053 2.261 1.358 12.095 1,016 527 77.04 0.854
≥10 Yes MAP Serology 3.863 1.600 1.716 8.699 1,638 697 75.80 0.526
≥10 No MAP Serology 4.516 2.644 1.434 14.229 975 511 77.63 0.948
These aORs were derived from models controlling for herd-type, herd-size, numbers of animals bought into the herd during the year of testing, region (based on District Veterinary
Officer areas), and also controlled for repeated measures within the same herd (herd random effect).
*This test was undertaken with fixed effects only.
with avian tuberculin can reduce interference of the ELISA blood
test (AWHNI), but if the tested animal has been exposed to
M. bovis, there is the potential for cross reactivity with the
MAP ELISA test. We investigated the potential impact of MAP
testing within a “risk window” prior to MAP testing during
the sensitivity analysis. This work supported the idea that there
may have been some impact of prior tuberculin testing on the
association between TB episode risk and MAP status—pushing
results toward the null. However, in models with greater MAP
sampling (≥3 samples) and excluding observations within the
risk window, there remained a strong positive association.
The effect of prior M. bovis exposure within herds (separate
from just the tuberculin use alone) could still impact on the
MAP test. While we believe this to be a risk for establishing
causation in our study design, there are lines of evidence that
suggest this risk to be low. There is 1. an annual testing regime
of all animals in Northern Ireland for bTB, where all skin test
reactors are culled (29), 2. follow-up stringent use of severe
interpretation and interferon gamma testing is undertaken (6), 3.
in some instances additional serological tests are deployed (42),
4. animals are managed so to reduce susceptible exposure to at-
risk groups, and 5. is coupled with post-mortem surveillance.
With this system, it is rare that disseminated infection is found
in reactor animals [∼45% have lesions, and most have very few
lesions; (43)], and therefore transmission within herds is low,
leading to small breakdown size [median <5 animals; (44)].
Therefore, the risk of MAP tested animals being exposed to M.
bovis is low, even within breakdown herds.We utilized additional
fecal data (culture and PCR) in an attempt to make our definition
of MAP infection more robust, however we had limited fecal
TABLE 4 | Cross-tabulation of bTB herd classification and herd status for MAP
using a serum ELISA test.
MAP serum
Herd classification Neg. Pos. Total
Chronic episodic herd* 175 125 300
% 58.33 41.67 100
Non-chronic episodic herd∧ 3,224 2,136 5,360
% 60.15 39.85 100
bTB free herds$ 3,090 1,469 4,559
% 67.78 32.22 100
Total 6,489 3,730 10,219
% 63.5 36.5 100
*A herd which experienced a prolonged (>365 days) or recurrent (1 breakdown of duration
<1 year, followed by two or more bTB breakdowns within 2 years) over a time-series
2004-2015 (32).
∧A non-chronic herd that experienced at least one episode during the time series.
$A herd which did not experience an episode during the time-series.
testing data available to inform our study (e.g., only 61 positive
test result herds in our study).
As the impact of co-infection can impact on both diagnostics
of bTB and MAP, and as MAP tests have low diagnostic
sensitivity, we performed a sensitivity analysis on the number
of samples used to infer a MAP status for herds. Interestingly,
with increasing the numbers of samples (presumably increasing
the sensitivity of the test (21), but also potential reducing the
specificity of the MAP test) we found the association between the
two pathogens increased, despite lowering the power to detect
Frontiers in Veterinary Science | www.frontiersin.org 8 February 2019 | Volume 6 | Article 30
Byrne et al. MAP Co-infection Impacts bTB Risk
an effect (by reducing the overall n). As the serum ELISA MAP
test has been shown to have reasonably high specificity for a
screening test across studies [0.95–1.00; (37)], and as we sampled
typically small numbers of animals per herd (mean 10), we do
not anticipate that MAP false positive results would be the major
factor influencing our inferences.
This work does add some evidence that exposure to non-
tuberculosis bacteria could be having an effect in Northern
Ireland (26, 30, 43). Barry et al. (30) showed using experimental
animal models that co-infection could affect the gamma
interferon test (but not necessarily the skin test). Using field
data, our group previously found that animals with large avian
tuberculin reactions (but CTT negative) had an increased risk
of being TB confirmed and having greater number of lesions at
slaughter, relative to non-reactor animals (26, 43). Such animals
were potentially exposed to non-tuberculosis mycobacteria
(including environmental exposure or MAP). Therefore, there
was a risk that some co-infected animals were missed during
antemortemTB testing. Coupled with the present study, there is a
strong argument for further investigation into the mechanism by
which MAP-bTB-coinfection is impacting on the bTB statutory
eradication program.
Our models used a parsimonious base model from which we
tested our co-infection hypothesis. This base model confirmed
that herd size, the act of buying in of cattle, regional variation
(likely representing spatial variation in underlying infection
pressure) are all very important explanatory factors for bovine
TB risk (34, 45). However, despite our previous work [e.g.,
(6, 31, 46)], there was less evidence that major enterprise
type was very important in our final model (though invariably
associated with the outcome). This could be related to our
ability to consistently categorize herd types in Northern Ireland.
In the present study we used two pieces of data available
to the study, herd type and having a milk license. Both are
recorded within the APHIS dataset, and both are known to have
limitations. For example, where farms change their enterprise
type, the recording of this change can be delayed within the
dataset. Furthermore, where there are mixed enterprises, it
is difficult to assign a single category. Despite this, we have
previously reported differential risk at both the herd [e.g., (44)]
and animal level [e.g., (43)] in Northern Ireland using similar
datasets. This covariate was not our primary interest during this
study, however further more refined “real-time” classification
of herds is required to improve epidemiological modeling in
Northern Ireland.
LIMITATIONS
Our models were based on retrospective observational datasets
that were not collected for this specific purpose, and therefore
the population they represent may not be fully representative
of herds in the broader population in Northern Ireland. Indeed,
inclusion criteria for the study was for voluntary participation in
a MAP control/surveillance scheme in Northern Ireland, which
may have introduced some selection bias. Furthermore, the
median number of samples taken per event was 1, and therefore
these animals are more likely representative of ‘suspect’ cases,
sampled as part of a veterinary investigations (though this is not
the case for CHS herds). Indeed, therefore, there may have been
some directed sampling toward the highest risk animals within
the cohort. A further problem with the low number of animals
tested per event is that, because of the sensitivity of the MAP
test, there was the risk of misclassifying the herds. However, we
addressed this with our sensitivity analysis. There was the overall
problem of assessing co-infections at the herd level, though they
have been undertaken previously [e.g., (47)]. Obviously, herds
are a dynamic collection of animals, which can move in (buying
in, birth) or out (market, abattoir, death) of herds. Therefore,
finding associations at this level of organization is probably
more biased toward the null than animal-level experimental
analyses where there is little ambiguity as to exposure to either
or both pathogens. Despite the limitations of this study, we
believe there are useful associations to build further inferences
about the dynamics of two difficult chronic pathogens of
cattle herds.
CONCLUSION
Wehave found robust associations between bTB herd breakdown
episode risk and concurrent MAP infections at the herd level.
This association was positive, indicating that breakdown herds
exhibited a higher risk of co-infection than sampled herds
which were not experiencing a breakdown. Furthermore, there
was a marginally higher proportion of chronically infected
herds with evidence of MAP infection than bTB free herds
over the study period. During the study we investigated
whether the sampling frequency of herds to determine MAP
status, and the time-period between a previous tuberculin
test and MAP test, had an impact on these associations.
Increasing sampling frequency increased the magnitude of
the point estimate associations and the uncertainty around
these estimates, while decreasing N. The sampling of animals
within a “risk window” where cross-reactivity may occur after
a TB tuberculin test did appear to impact the association
by increasing uncertainty and lowering the magnitude of the
association. The exact mechanism for our findings cannot be
readily determined with these data, however we hypothesize
given results from elsewhere that MAP may be masking
bTB infection in herds experiencing TB breakdowns. This
masking effect may impact on the ability to identify exposed
cattle, cull them, and thus clear infection. Further research is
required to better understand how these patterns emerge, and
whether (or which) co-management tools would yield optimal
control benefits.
AUTHOR CONTRIBUTIONS
AB conceived and designed the study, project managed,
undertook data analysis, and interpretation of data for the
paper. AB drafted the initial manuscript and revised it critically.
JG managed all research databases contributing to the work,
and was involved in data merging, validation, and cleaning,
Frontiers in Veterinary Science | www.frontiersin.org 9 February 2019 | Volume 6 | Article 30
Byrne et al. MAP Co-infection Impacts bTB Risk
and contributed to data interpretation. GM was involved
in generating the chronic herds data set and episode file,
contributed to the data interpretation, and critically revised
the manuscript. MG-G led and coordinated the AFBI cattle
health scheme (2010–2018) which contributed data, managed
the diagnostic laboratories undertakingMAP testing, contributed
to data interpretation and study design, and critically revised
the manuscript. SS was involved in the initial concept for
the work, managed a Johne’s control program (AHWNI) in
Northern Ireland which contributed data, contributed to data
interpretation and study design, and critically revised the
manuscript. All authors read and made comments and/or edits
to the final manuscript.
FUNDING
Funding was provided as part of the Evidence and Innovation
Strategy from the Department of Agriculture, Environment,
and Rural Affairs (DAERA; Grant numbers: 15/03/08
Tuberculosis in chronic herds in Northern Ireland; PI: AB;
15/03/10 Concurrent endemic diseases in Northern Ireland;
PI: AB). Open access publication fees were institutionally
funded (AFBI).
ACKNOWLEDGMENTS
Wewould like to acknowledge the laboratory staff at DSIB, AFBI.
We also wish to acknowledge colleagues within Epidemiology,
Molecular biology, and Immunology (EMbI; https://twitter.com/
AFBI_EMbI) research cluster within Bacteriology branch AFBI
for stimulating discussions about this topic and help in the
thinking around this confection problem. Data were provided
by DAERA (data controllers) under a data sharing agreement
to AFBI.
SUPPLEMENTARY MATERIAL




1. Benedictus G, Verhoeff J, Schukken YH, Hesselink JW. Dutch
paratuberculosis programme history, principles and development. Vet
Microbiol. (2000) 77:399–413. doi: 10.1016/S0378-1135(00)00325-4
2. Olmstead AL, Rhode PW. An impossible undertaking: the eradication of
bovine tuberculosis in the United States. J Econ History (2004) 64:734–72.
doi: 10.1017/S0022050704002955
3. Gordejo FR, Vermeersch JP. Towards eradication of bovine
tuberculosis in the European Union. Vet Microbiol. (2006) 112:101–9.
doi: 10.1016/j.vetmic.2005.11.034
4. Reynolds D. A review of tuberculosis science and policy in Great Britain. Vet
Microbiol. (2006) 112:119–26. doi: 10.1016/j.vetmic.2005.11.042
5. Allen A, Skuce R, Byrne A. Bovine tuberculosis in Britain and Ireland–A
Perfect Storm? The confluence of potential ecological and epidemiological
impediments to controlling a chronic infectious disease Front. Veterin. Sci.
(2018) 5:109. doi: 10.3389/fvets.2018.00109
6. Lahuerta-Marin A, Gallagher M, McBride S, Skuce R, Menzies F, McNair
J, et al. Should they stay, or should they go? Relative future risk of bovine
tuberculosis for interferon-gamma test-positive cattle left on farms. Vet Res.
(2015) 46:90. doi: 10.1186/s13567-015-0242-8
7. De la Rua-Domenech R, Goodchild AT, Vordermeier HM, Hewinson
RG, Christiansen KH, Clifton-Hadley RS. Ante mortem diagnosis of
tuberculosis in cattle: a review of the tuberculin tests, γ-interferon assay
and other ancillary diagnostic techniques. Res Vet Sci. (2006) 81:190–210.
doi: 10.1016/j.rvsc.2005.11.005
8. Clegg TA, Duignan A, Whelan C, Gormley E, Good M, Clarke J, et al.
Using latent class analysis to estimate the test characteristics of the γ-
interferon test, the single intradermal comparative tuberculin test and a
multiplex immunoassay under Irish conditions. Vet Microbiol. (2011) 151:68–
76. doi: 10.1016/j.vetmic.2011.02.027
9. Nuñez-Garcia JSH, Downs JE, Parry DA, Abernethy JM, Broughan
AR, Cameron AJ, Cook et al. Meta-analyses of the sensitivity and
specificity of ante-mortem and post-mortem diagnostic tests for bovine
tuberculosis in the, UK and Ireland. Prev Vet Med. (2018) 153:94.
doi: 10.1016/j.prevetmed.2017.02.017
10. Lahuerta-Marin A, Milne MG, McNair J, Skuce R, McBride S, Menzies F, et al.
Bayesian latent class estimation of sensitivity and specificity parameters of
diagnostic tests for bovine tuberculosis in chronic herds-Northern Ireland.Vet
J. (2018) 238:15–21. doi: 10.1016/j.tvjl.2018.04.019
11. Murphy D, Gormley E, Costello E, O’Meara D, Corner LAL. The
prevalence and distribution of Mycobacterium bovis infection in
European badgers (Meles meles) as determined by enhanced post mortem
examination and bacteriological culture. Res Vet Sci. (2010) 88:1–5.
doi: 10.1016/j.rvsc.2009.05.020
12. Byrne AW, Kenny K, Fogarty U, O’Keeffe JJ, More SJ, McGrath G, et al. Spatial
and temporal analyses of metrics of tuberculosis infection in badgers (Meles
meles) from the Republic of Ireland: trends in apparent prevalence. Prev Vet
Med. (2015) 122:345–54. doi: 10.1016/j.prevetmed.2015.10.013
13. Griffin JM, Williams DH, Kelly GE, Clegg TA, O’boyle I, Collins JD,
et al. The impact of badger removal on the control of tuberculosis
in cattle herds in Ireland. Prev. Vet. Med. (2005) 67:237–266.
doi: 10.1016/j.prevetmed.2004.10.009
14. Donnelly CA, Nouvellet P. The contribution of badgers to confirmed
tuberculosis in cattle in high-incidence areas in England. PLoS Curr. (2013)
5. doi: 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098
15. Cox DR, Donnelly CA, Bourne FJ, Gettinby G, McInerney JP, Morrison WI,
et al. Simple model for tuberculosis in cattle and badgers. Proc Nat Acad Sci
USA. (2005) 102:17588–93. doi: 10.1073/pnas.0509003102
16. Aznar I, Frankena K, Byrne AW, More SJ, De Jong MCM. Infection dynamics
and effective control options of tuberculosis in cattle and badgers. In: 6th
International M. bovis Conference. (Cardiff) (2014).
17. Brooks-Pollock E, Wood JL. Eliminating bovine tuberculosis in cattle and
badgers: insight from a dynamic model. Proc. R. Soc. B. (2015) 282:20150374.
doi: 10.1098/rspb.2015.0374
18. Ott SL, Wells SJ, Wagner BA. Herd-level economic losses associated with
Johne’s disease on US dairy operations. Prev Vet Med. (1999) 40:179–92.
doi: 10.1016/S0167-5877(99)00037-9
19. More SJ, McKenzie K, O’Flaherty J, Doherty ML, Cromie AR, Magan MJ.
Setting priorities for non-regulatory animal health in Ireland: results from an
expert Policy Delphi study and a farmer priority identification survey. Prev
Vet Med. (2010) 95:198–207.
20. Dunn JR, Kaneene JB, Grooms DL, Bolin SR, Bolin CA, Bruning-Fann CS.
Effects of positive results for Mycobacterium avium subsp paratuberculosis
as determined by microbial culture of feces or antibody ELISA on results of
caudal fold tuberculin test and interferon-γ assay for tuberculosis in cattle. J
Am Vet Med Assoc. (2005) 226;429–435. doi: 10.2460/javma.2005.226.429
21. Hope JC, Thom ML, Villarreal-Ramos B, Vordermeier H M, Hewinson
RG, Howard CJ. Exposure to Mycobacterium avium induces low-
level protection from Mycobacterium bovis infection but compromises
Frontiers in Veterinary Science | www.frontiersin.org 10 February 2019 | Volume 6 | Article 30
Byrne et al. MAP Co-infection Impacts bTB Risk
diagnosis of disease in cattle. Clin Exp Immunol. (2005) 141:432–439.
doi: 10.1111/j.1365-2249.2005.02882.x
22. Aranaz A, Bezos J, Álvarez J, Romero B, Lozano F, Paramio JL., et al.
Assessment of diagnostic tools for eradication of bovine tuberculosis in cattle
co-infected with Mycobacterium bovis and M. avium subsp. paratuberculosis.
Vet. Res. (2006) 37:593–606.
23. Álvarez J, De Juan L, Bezos J, Romero B, Sáez JL, Marqués S, et al. Effect of
paratuberculosis on the diagnosis of bovine tuberculosis in a cattle herd with
a mixed infection using interferon-gamma detection assay. Vet. Microbiol.
(2009) 135:389–393.
24. Roupie V, Alonso-Velasco E, Van Der Heyden S, Holbert S, Duytschaever L,
Berthon P, et al. Evaluation of mycobacteria-specific gamma interferon and
antibody responses before and after a single intradermal skin test in cattle
naturally exposed to M. avium subsp paratuberculosis and experimentally
infected with M. bovis. Vet Immunol Immunopathol. (2018) 196:35–47.
doi: 10.1016/j.vetimm.2017.12.007
25. Kennedy AE, Byrne N, O’Mahony J, Sayers RG. Investigations and
implications of associations betweenmycobacterial purified protein derivative
hypersensitivity and MAP-antibody ELISA in Irish dairy cows. Res Vet Sci.
(2017) 115:13–6. doi: 10.1016/j.rvsc.2017.01.018
26. Byrne AW, Graham J, Brown C, Donaghy A, Guelbenzu-Gonzalo M, McNair
J, et al. Modelling the variation in skin-test tuberculin reactions, post-mortem
lesion counts and case pathology in tuberculosis-exposed cattle: Effects of
animal characteristics, histories and co-infection. Transbound Emerg Dis.
(2018) 65:844–58. doi: 10.1111/tbed.12814
27. Lilenbaum W, Marassi CD, Varges R, Medeiros L, Oelemann WMR,
Fonseca LS. Occurrence of false-positive results in three Paratuberculosis-
ELISAs performed in a tuberculous herd. Vet Res Comm. (2009) 33:693–9.
doi: 10.1007/s11259-009-9218-3
28. May H, Orpin P, Pearse H, Jones P, Clough H. The Influence of Tuberculosis
Testing in Dairy Cattle on Milk ELISA Tests for Johne’s Disease (2008).
Available online at: https://www.researchgate.net/publication/237445560_
The_influence_of_tuberculosis_testing_in_dairy_cattle_on_milk_ELISA_
tests_for_Johne’s_disease
29. Abernethy DA, Denny GO, Menzies FD, McGuckian P, Honhold N,
Roberts AR. The Northern Ireland programme for the control and
eradication of Mycobacterium bovis. Vet Microbiol. (2006) 112:231–7.
doi: 10.1016/j.vetmic.2005.11.023
30. Barry C, Corbett D, Bakker D, Andersen P, McNair J, Strain S. The effect
of Mycobacterium avium complex infections on routine Mycobacterium
bovis diagnostic tests. Vet. Med. Int. (2011) 2011:145092 doi: 10.4061/2011/
145092
31. Milne GM, Graham J, Allen A, Lahuerta-Marin A, McCormick C, Presho E,
et al. Spatiotemporal analysis of prolonged and recurrent bovine tuberculosis
breakdowns in Northern Irish cattle herds reveals a new infection hotspot.
Spatial Spatio-Temporal Epidemiol. (2019) 28:33–42. doi: 10.1016/j.sste.2018.
11.002
32. Milne G, Graham J, Allen A, Lahuerta-Marin A,McCormick C, Presho E, et al.
Herd characteristics, wildlife risk and bacterial strain genotypes in persistent
breakdowns of bovine tuberculosis in Northern Irish cattle herds. In: Society
for Veterinary Epidemiology and Preventive Medicine–Proceedings. Tallinn,
Estonia. (2018). p. 21–3.
33. Skuce RA, Byrne AW, Lahuerta-Marin A, Allen A. Chapter 5.Mycobacterium
bovis molecular typing and surveillance. In: Chambers M, Gordon S, Olea-
Popelka F, Barrow P, editors. Bovine Tuberculosis. Wallingford, VT: CABI
(2018). p. 58–79. doi: 10.1079/9781786391520.0058
34. Skuce RA, Allen AR, McDowell SW. Herd-level risk factors for bovine
tuberculosis: a literature review. Vet Med Int. (2012) 2102:621210.
doi: 10.1155/2012/621210.
35. Dohoo IR, Martin SW, Stryhn H. Veterinary Epidemiologic Research.
Charlottetown, PE: AVC Inc (2009).
36. Alinovi CA, Ward MP, Lin TL, Moore GE, Wu CC. Real-time PCR,
compared to liquid and solid culture media and ELISA, for the detection of
Mycobacterium avium ssp. paratuberculosis Vet Microbiol. (2009) 136:177–9.
doi: 10.1016/j.vetmic.2008.10.012
37. Nielsen SS, Toft N. Ante mortem diagnosis of paratuberculosis: a review of
accuracies of ELISA, interferon-γ assay and faecal culture techniques. Vet
Microbiol. (2008) 129:217–35. doi: 10.1016/j.vetmic.2007.12.011
38. Meyer A, Bond K, Van Winden S, Green M, Guitian J. A probabilistic
approach to the interpretation of milk antibody results for diagnosis
of Johne’s disease in dairy cattle. Prev Vet Med. (2018) 150:30–7.
doi: 10.1016/j.prevetmed.2017.11.016
39. Kennedy AE, Da Silva AT, Byrne N, Govender R, MacSharry J, O’Mahony
J, et al. The single intradermal cervical comparative test interferes
with Johne’s disease ELISA diagnostics. Front Immunol. (2014) 5:564.
doi: 10.3389/fimmu.2014.00564
40. Seva J, Sanes JM, Ramis G, Mas A, Quereda JJ, Villarreal-Ramos B,
et al. Evaluation of the single cervical skin test and interferon gamma
responses to detect Mycobacterium bovis infected cattle in a herd co-infected
with Mycobacterium avium subsp. paratuberculosis. Vet. Microbiol. (2014)
171:139–46. doi: 10.1016/j.vetmic.2014.03.035
41. Raffo E, Steuer P, Monti G, Salgado M. Effect of Mycobacterium avium
subsp. paratuberculosis (MAP) infection on the diagnostic accuracy for
Mycobacterium bovis (M bovis) infection under field conditions in cattle
belonging to low M bovis prevalence herds Trop Anim Health Prod. (2017)
49:771–5. doi: 10.1007/s11250-017-1259-y
42. McCallan L, Brooks C, Couzens C, Young F, McNair J, Byrne AW. Assessment
of serological tests for diagnosis of bovine tuberculosis. Vet Record (2017)
181:90. doi: 10.1136/vr.104272
43. Byrne AW, Guelbenzu-Gonzalo M, Strain SAJ, McBride S, Graham J,
Lahuerta-Marin A, et al. Assessment of concurrent infection with bovine
viral diarrhoea virus (BVDV) and Mycobacterium bovis: a herd-level risk
factor analysis from Northern Ireland. Prev Vet Med. (2017) 141:38–47.
doi: 10.1016/j.prevetmed.2017.04.007
44. Byrne AW, Graham J, Brown C, Donaghy A, Guelbenzu-Gonzalo M, McNair
J, et al. Bovine tuberculosis visible lesions in cattle culled during herd
breakdowns: the effects of individual characteristics, trade movement and
co-infection. BMC Vet. Res. (2017) 13:400. doi: 10.1186/s12917-017-1321-z
45. Broughan JM, Judge J, Ely E, Delahay RJ, Wilson G, Clifton-Hadley
RS, et al. A review of risk factors for bovine tuberculosis infection in
cattle in the UK and Ireland. Epidemiol Infect. (2016) 144:2899–926.
doi: 10.1017/S095026881600131X
46. Lahuerta-Marin A, McNair J, Skuce R, McBride S, Allen M, Strain SA, et al.
Risk factors for failure to detect bovine tuberculosis in cattle from infected
herds across Northern Ireland (2004–2010). Res Vet Sci. (2016) 107:233–9.
doi: 10.1016/j.rvsc.2016.06.014
47. Vanleeuwen JA, Haddad JP, Dohoo IR, Keefe GP, Tiwari A, Scott HM.
Risk factors associated with Neospora caninum seropositivity in randomly
sampled Canadian dairy cows and herds. Prev Vet Med. (2010) 93:129–138.
doi: 10.1016/j.prevetmed.2009
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Byrne, Graham, Milne, Guelbenzu-Gonzalo and Strain. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Veterinary Science | www.frontiersin.org 11 February 2019 | Volume 6 | Article 30
